Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Gengaro has maintained a Hold rating on Core Laboratories (NYSE:CLB) but has reduced the price target from $23 to $21.
January 29, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel has maintained a Hold rating on Core Laboratories and lowered the price target from $23 to $21, indicating a potential downside or limited upside.
The reduction in price target by Stifel suggests that the analyst sees less potential for price appreciation in Core Laboratories' stock. This could lead to a negative perception among investors and potentially cause a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100